Revenue has stayed near $112B per quarter while the loss ratio swung between 67.3% and 83.7% over the period, suggesting that medical cost trends rather than top-line expansion are driving the earnings profile.
UnitedHealth Group Incorporated (UNH) annual income statement — 30-year revenue, gross profit & net income history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Revenue | 449.66B | 447.57B | 400.28B | 371.62B | 324.16B | 287.6B | 257.14B | 242.16B | 226.25B | 201.16B | 184.84B | 157.11B | 130.47B | 122.49B | 110.62B | 101.86B | 94.16B | 87.14B | 81.19B | 75.43B | 71.54B | 46.43B | 37.22B | 28.57B | 25.02B | 23.45B | 21.12B | 19.56B | 17.36B | 11.79B | 10.07B |
| Revenue Growth % | 3.33% | 11.81% | 7.71% | 14.64% | 12.71% | 11.84% | 6.19% | 7.03% | 12.47% | 8.83% | 17.65% | 20.41% | 6.52% | 10.73% | 8.6% | 8.19% | 8.05% | 7.33% | 7.63% | 5.44% | 54.08% | 24.76% | 30.29% | 14.17% | 6.68% | 11.04% | 7.97% | 12.72% | 47.15% | 17.08% | 77.64% |
| Medical Costs & Claims | 347.08B | 364.65B | 310.88B | 280.66B | 244.54B | 217.94B | 190.14B | 184.56B | 172.4B | 154.15B | 141.45B | 120.08B | 97.04B | 92.13B | 82.75B | 92.27B | 85.23B | 79.79B | 61.84B | 56.2B | 53.91B | 32.73B | 27B | 20.71B | 18.19B | 21.62B | 16.16B | 15.04B | 13.52B | 8.54B | 7.18B |
| Medical Cost Ratio % | 77.19% | 81.47% | 77.67% | 75.52% | 75.44% | 75.78% | 73.94% | 76.21% | 76.2% | 76.63% | 76.53% | 76.43% | 74.38% | 75.21% | 74.81% | 90.59% | 90.52% | 91.57% | 76.17% | 74.51% | 75.35% | 70.48% | 72.55% | 72.51% | 72.71% | 92.19% | 76.48% | 76.9% | 77.92% | 72.43% | 71.27% |
| Gross Profit | 102.58B | 82.92B | 89.4B | 90.96B | 79.62B | 69.65B | 67B | 57.6B | 53.85B | 47.01B | 43.39B | 37.03B | 33.43B | 30.36B | 27.87B | 9.59B | 8.93B | 7.35B | 19.35B | 19.23B | 16.76B | 12.14B | -28.64B | 7.85B | 6.83B | 1.83B | 4.97B | 4.52B | 3.83B | 3.25B | 2.89B |
| Gross Margin % | 22.81% | 18.53% | 22.33% | 24.48% | 24.56% | 24.22% | 26.06% | 23.79% | 23.8% | 23.37% | 23.47% | 23.57% | 25.62% | 24.79% | 25.19% | 9.41% | 9.48% | 8.43% | 23.83% | 25.49% | 23.43% | 26.15% | -76.96% | 27.49% | 27.29% | 7.81% | 23.52% | 23.1% | 22.08% | 27.57% | 28.73% |
| Gross Profit Growth % | - | -7.25% | -1.71% | 14.24% | 14.31% | 3.96% | 16.32% | 6.97% | 14.54% | 8.36% | 17.18% | 10.75% | 10.12% | 8.94% | 190.67% | 7.39% | 21.47% | -62.01% | 0.62% | 14.7% | 38.08% | 142.39% | -464.77% | 15% | 272.91% | -63.14% | 9.91% | 17.93% | 17.84% | 12.37% | 66.33% |
| Operating Expenses | 78.66B | 63.95B | 57.11B | 58.6B | 51.18B | 45.68B | 44.59B | 37.91B | 36.5B | 31.8B | 30.46B | 26B | 23.16B | 20.74B | 18.61B | 1.12B | 1.06B | 991M | 14.08B | 11.38B | 10.65B | 7.27B | -32.74B | 5.17B | 4.64B | 265M | 3.77B | 3.58B | 3.87B | 2.51B | 2.3B |
| OpEx / Revenue % | 17.49% | 14.29% | 14.27% | 15.77% | 15.79% | 15.88% | 17.34% | 15.66% | 16.13% | 15.81% | 16.48% | 16.55% | 17.75% | 16.93% | 16.83% | 1.1% | 1.13% | 1.14% | 17.35% | 15.09% | 14.89% | 15.65% | -87.98% | 18.11% | 18.55% | 1.13% | 17.83% | 18.28% | 22.32% | 21.28% | 22.81% |
| Depreciation & Amortization | 4.26B | 4.36B | 4.1B | 3.97B | 3.4B | 3.1B | 2.89B | 2.72B | 2.43B | 2.25B | 2.06B | 1.69B | 1.48B | 1.38B | 1.31B | 1.12B | 1.06B | 991M | 981M | 796M | 670M | 453M | 374M | 299M | 255M | 265M | 247M | 233M | 185M | 146M | 133.17M |
| Combined Ratio % | 94.68% | 95.76% | 91.93% | 91.29% | 91.23% | 91.67% | 91.29% | 91.87% | 92.33% | 92.44% | 93% | 92.99% | 92.13% | 92.14% | 91.63% | 91.69% | 91.65% | 92.7% | 93.52% | 89.59% | 90.24% | 86.13% | -15.43% | 90.63% | 91.26% | 93.32% | 94.32% | 95.18% | 100.24% | 93.71% | 94.08% |
| Operating Income | 23.92B | 18.96B | 32.29B | 32.36B | 28.43B | 23.97B | 22.41B | 19.68B | 17.34B | 15.21B | 12.93B | 11.02B | 10.27B | 9.62B | 9.25B | 8.46B | 7.86B | 6.36B | 5.26B | 7.85B | 6.98B | 5.08B | 4.1B | 2.67B | 2.19B | 1.57B | 1.2B | 943M | -42M | 742M | 596.41M |
| Operating Margin % | 5.32% | 4.24% | 8.07% | 8.71% | 8.77% | 8.33% | 8.71% | 8.13% | 7.67% | 7.56% | 7% | 7.01% | 7.87% | 7.86% | 8.37% | 8.31% | 8.35% | 7.3% | 6.48% | 10.41% | 9.76% | 10.94% | 11.02% | 9.35% | 8.74% | 6.68% | 5.68% | 4.82% | -0.24% | 6.29% | 5.92% |
| Operating Income Growth % | - | -41.26% | -0.22% | 13.8% | 18.63% | 6.98% | 13.82% | 13.5% | 14.04% | 17.63% | 17.32% | 7.27% | 6.77% | 3.99% | 9.33% | 7.63% | 23.67% | 20.82% | -32.95% | 12.39% | 37.48% | 23.87% | 53.54% | 22.19% | 39.59% | 30.5% | 27.25% | 2345.24% | -105.66% | 24.41% | 29.43% |
| EBITDA | 28.18B | 23.32B | 36.39B | 36.33B | 31.84B | 27.07B | 25.3B | 22.41B | 19.77B | 17.45B | 14.98B | 12.71B | 11.75B | 11B | 10.56B | 9.59B | 8.93B | 7.35B | 6.24B | 8.64B | 7.65B | 5.53B | 4.47B | 2.97B | 2.44B | 1.83B | 1.45B | 1.18B | 143M | 888M | 729.58M |
| EBITDA Margin % | 6.27% | 5.21% | 9.09% | 9.78% | 9.82% | 9.41% | 9.84% | 9.25% | 8.74% | 8.68% | 8.11% | 8.09% | 9.01% | 8.98% | 9.55% | 9.41% | 9.48% | 8.43% | 7.69% | 11.46% | 10.7% | 11.92% | 12.02% | 10.4% | 9.76% | 7.81% | 6.85% | 6.01% | 0.82% | 7.53% | 7.24% |
| Interest Expense | 3.85B | 4B | 3.91B | 3.25B | 2.09B | 1.66B | 1.66B | 1.7B | 1.4B | 1.19B | 1.07B | 790M | 618M | 708M | 632M | 505M | 481M | 551M | 639M | 544M | 456M | 241M | 128M | 95M | 90M | 94M | 0 | 0 | 0 | 0 | 0 |
| Non-Operating Income | 191M | 265M | 8.31B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -27.02B | 0 | 0 | 0 | -37.24B | -725M | 0 | -14.97M |
| Pretax Income | 19.73B | 14.7B | 20.07B | 29.11B | 26.34B | 22.31B | 20.74B | 17.98B | 15.94B | 14.02B | 11.86B | 10.23B | 9.66B | 8.91B | 8.62B | 7.96B | 7.38B | 5.81B | 4.62B | 7.3B | 6.53B | 4.84B | 3.97B | 2.84B | 2.1B | 1.47B | 1.16B | 894M | -46M | 742M | 580.85M |
| Pretax Margin % | 4.39% | 3.28% | 5.01% | 7.83% | 8.13% | 7.76% | 8.07% | 7.43% | 7.05% | 6.97% | 6.42% | 6.51% | 7.4% | 7.28% | 7.79% | 7.81% | 7.84% | 6.67% | 5.7% | 9.68% | 9.12% | 10.42% | 10.67% | 9.94% | 8.38% | 6.28% | 5.47% | 4.57% | -0.27% | 6.29% | 5.77% |
| Income Tax | 3.07B | 1.89B | 4.83B | 5.97B | 5.7B | 4.58B | 4.97B | 3.74B | 3.56B | 3.2B | 4.79B | 4.36B | 4.04B | 3.24B | 3.1B | 2.82B | 2.75B | 1.99B | 1.65B | 2.65B | 2.37B | 1.76B | 1.39B | 1.01B | 744M | 559M | 419M | 326M | 120M | 282M | 224.6M |
| Effective Tax Rate % | 15.54% | 12.86% | 24.06% | 20.5% | 21.65% | 20.52% | 23.98% | 20.81% | 22.34% | 22.82% | 40.38% | 42.64% | 41.81% | 36.37% | 35.91% | 35.39% | 37.23% | 34.19% | 35.62% | 36.29% | 36.29% | 36.29% | 34.89% | 35.74% | 35.5% | 37.98% | 36.28% | 36.47% | -260.87% | 38.01% | 38.67% |
| Net Income | 15.88B | 12.06B | 14.4B | 22.38B | 20.12B | 17.29B | 15.4B | 13.84B | 11.99B | 10.56B | 7.02B | 5.81B | 5.62B | 5.63B | 5.53B | 5.14B | 4.63B | 3.82B | 2.98B | 4.65B | 4.16B | 3.08B | 2.59B | 1.66B | 1.35B | 913M | 736M | 568M | -166M | 460M | 355.64M |
| Net Margin % | 3.53% | 2.69% | 3.6% | 6.02% | 6.21% | 6.01% | 5.99% | 5.71% | 5.3% | 5.25% | 3.8% | 3.7% | 4.31% | 4.59% | 5% | 5.05% | 4.92% | 4.39% | 3.67% | 6.17% | 5.81% | 6.64% | 6.95% | 5.79% | 5.4% | 3.89% | 3.48% | 2.9% | -0.96% | 3.9% | 3.53% |
| Net Income Growth % | -9.69% | -16.31% | -35.64% | 11.24% | 16.4% | 12.22% | 11.3% | 15.46% | 13.53% | 50.46% | 20.71% | 3.45% | -0.11% | 1.79% | 7.47% | 10.96% | 21.25% | 28.38% | -36.03% | 11.9% | 34.9% | 19.17% | 56.31% | 22.41% | 48.08% | 24.05% | 29.58% | 442.17% | -136.09% | 29.35% | 24.36% |
| EPS (Diluted) | 17.61 | 13.23 | 15.51 | 23.86 | 21.18 | 18.08 | 16.03 | 14.33 | 12.19 | 10.72 | 7.25 | 6.01 | 5.70 | 5.50 | 5.28 | 4.73 | 4.10 | 3.24 | 2.40 | 3.42 | 2.97 | 2.31 | 1.83 | 1.34 | 1.07 | 0.70 | 0.55 | 0.40 | -0.14 | 0.28 | 0.22 |
| EPS Growth % | -8.55% | -14.7% | -35% | 12.65% | 17.15% | 12.79% | 11.86% | 17.56% | 13.71% | 47.86% | 20.63% | 5.44% | 3.64% | 4.17% | 11.63% | 15.37% | 26.54% | 35% | -29.82% | 15.15% | 28.57% | 26.23% | 36.57% | 25.23% | 52.86% | 27.27% | 37.5% | 385.71% | -150% | 27.27% | 10% |
| EPS (Basic) | - | 13.23 | 15.64 | 24.12 | 21.54 | 18.33 | 16.28 | 14.55 | 12.45 | 10.95 | 7.37 | 6.10 | 5.78 | 5.59 | 5.38 | 4.81 | 4.14 | 3.27 | 2.45 | 3.55 | 3.09 | 2.44 | 1.93 | 1.40 | 1.12 | 0.73 | 0.57 | 0.41 | -0.14 | 0.29 | 0.22 |
| Diluted Shares Outstanding | 902M | 910M | 929M | 938M | 950M | 956M | 961M | 966M | 983M | 985M | 968M | 967M | 986M | 1.02B | 1.05B | 1.09B | 1.13B | 1.18B | 1.24B | 1.36B | 1.4B | 1.33B | 1.32B | 1.24B | 1.27B | 1.3B | 1.35B | 1.42B | 1.52B | 1.53B | 1.49B |
Quick answers to the most common questions about buying UNH stock.
For fiscal year 2025, UnitedHealth Group Incorporated (UNH) reported total revenue of $447.57B. This represents a 4342.9% increase compared to $10.07B in 1996.
UnitedHealth Group Incorporated (UNH) is profitable, generating $12.06B in net income for the fiscal year ending 2025 with a net profit margin of 2.7%.
UnitedHealth Group Incorporated (UNH) reported an operating income of $18.96B, resulting in an operating profit margin of 4.2%. This margin reflects the operational efficiency of the business before interest and taxes.
UnitedHealth Group Incorporated (UNH) generated $82.92B in gross profit for the year, representing a gross profit margin of 18.5%. This demonstrates the company's core pricing power and production efficiency.
Key Metrics
Top Statement Risk
Medicare Advantage utilization and DOJ scrutiny
Metrics are mathematically derived from official filings.
Medical Cost Pressure Dominates Underwriting Results
Based on reported figures, UNH's combined ratio moved from 91.7% in 2025Q1 to 99.7% in 2025Q4 before recovering to 94.2% in 2026Q3, indicating underwriting margins remain sensitive to medical cost swings across the period.
The loss ratio ranged from roughly 67% to 84% over the ten quarters shown, with the 2025 peak coinciding with elevated utilization among senior members. A combined ratio above 100% would mean underwriting losses that depend on investment income to produce profit, and the 2025Q4 print came close to that threshold. Investors should monitor whether the 2026 recovery reflects durable cost control or favorable timing in reserve estimates.
Revenue Growth Slows as Premium Base Matures
As reported in the quarterly financial statements, UNH's revenue growth decelerated from double-digit rates in 2025 to roughly flat in 2026Q3 at negative 0.4%, suggesting premium pricing and membership gains are no longer offsetting cost resets.
Revenue expansion through 2025 was strong, but the sequential stall in 2026 may indicate limits to premium repricing in Medicare Advantage and commercial books. Flat top-line growth paired with a rising EPS trajectory in the latest quarters points to margin-driven earnings rather than volume-driven expansion. Sustained revenue stagnation would challenge the thesis that Optum-driven service revenue can carry consolidated growth.
Quarterly EPS Swings Warrant Reserve Scrutiny
Based on UNH's reported figures, diluted EPS fell from $6.85 in 2025Q1 to $0.01 in 2025Q4 before rebounding to $6.90 in 2026Q1, a volatility pattern that may reflect prior-year reserve development rather than run-rate earnings.
Sharp quarterly earnings compression of this magnitude is often linked to reserve adjustments on medical claims incurred in earlier periods. The reported data do not isolate prior-year development, so the underlying current-period cost run-rate cannot be determined from this snapshot. Analysts should strip out reserve movements before extrapolating recent EPS levels.
Regulatory Exposure Could Reverse Recent Gains
Recent disclosures note ongoing DOJ investigations into Medicare Advantage coding practices, a risk that a beat-and-raise quarter such as the reported 2026Q3 EPS of $4.56 does not mitigate and that could pressure forward earnings.
If the DOJ inquiry results in material penalties or required changes to risk-adjustment coding, the Medicare Advantage franchise and Optum Health economics could be materially affected. The strong Q3 result may reflect cost discipline, but it does not resolve the underlying legal exposure. Resolution timing and financial impact remain unquantified in the supplied data and warrant further investigation.
Scale Advantages Versus Peer Margin Compression
Based on peer context data, UNH's operating margin of the broader group sits well above CNC's negative 3.9% and HUM's 1.1%, though the supplied peer set does not isolate UNH's own operating margin, limiting direct comparison.
Peer data indicate the managed care group is under broad margin strain, with several competitors reporting thin or negative operating margins. UNH's scale and vertically integrated Optum structure may support a more resilient expense base, but the supplied figures do not allow a direct measurement of its expense ratio efficiency. Investors should treat relative-scale conclusions as provisional until segment-level expense data are reviewed.